Lilleby W - Search Results

1

Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up.

Lilleby W, Stensvold A, Dahl AA. Lilleby W, et al. Acta Oncol. 2014 Oct;53(10):1380-9. doi: 10.3109/0284186X.2014.916042. Epub 2014 May 20. Acta Oncol. 2014. PMID: 24844918

2

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.

Lilleby W, Fosså SD, Waehre HR, Olsen DR. Lilleby W, et al. Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):735-43. doi: 10.1016/s0360-3016(98)00475-1. Int J Radiat Oncol Biol Phys. 1999. PMID: 10098428

3

Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose.

Lilleby W, Dale E, Olsen DR, Gude U, Fosså SD. Lilleby W, et al. Acta Oncol. 2003;42(1):10-4. doi: 10.1080/0891060310002177. Acta Oncol. 2003. PMID: 12665325

4

10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy.

Berg A, Lilleby W, Bruland OS, Fosså SD. Berg A, et al. Among authors: lilleby w. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1074-83. doi: 10.1016/j.ijrobp.2007.04.031. Epub 2007 Aug 20. Int J Radiat Oncol Biol Phys. 2007. PMID: 17703896

5

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.

Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3. Fransson P, et al. Lancet Oncol. 2009 Apr;10(4):370-80. doi: 10.1016/S1470-2045(09)70027-0. Epub 2009 Mar 13. Lancet Oncol. 2009. PMID: 19286422 Clinical Trial.

6

Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center.

Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S. Stensvold A, et al. Among authors: lilleby w. Acta Oncol. 2011 Apr;50(3):408-14. doi: 10.3109/0284186X.2010.492236. Epub 2010 Jun 30. Acta Oncol. 2011. PMID: 20586661

7

Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones.

Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S. Stensvold A, et al. Among authors: lilleby w. Prostate. 2012 May 1;72(6):668-76. doi: 10.1002/pros.21470. Epub 2011 Aug 1. Prostate. 2012. PMID: 21809351

8

Detection of prostate cancer relapse with PET/CT using a novel radiotracer.

Lilleby W, Willoch F, Stensvold A. Lilleby W, et al. Acta Oncol. 2012 Mar;51(3):397-9. doi: 10.3109/0284186X.2011.614638. Epub 2011 Sep 22. Acta Oncol. 2012. PMID: 21936756 No abstract available.

9

Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancer.

Lilleby W, Tafjord G, Raabe NK. Lilleby W, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):933-9. doi: 10.1016/j.ijrobp.2011.08.028. Epub 2011 Dec 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 22138456

10

Bother problems in prostate cancer patients after curative treatment.

Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S. Stensvold A, et al. Among authors: lilleby w. Urol Oncol. 2013 Oct;31(7):1067-78. doi: 10.1016/j.urolonc.2011.12.020. Epub 2012 Feb 16. Urol Oncol. 2013. PMID: 22341412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page